Lupin Launches Erectile Dysfunction Tablets in US, Stocks Fall
The company's product is the generic version of Pfizer Inc's Viagra tablets in the same strengths, Lupin said.
Representative Image (Photo Credit: AFP)
New Delhi: Pharma major Lupin on Monday said it has launched its Sildenafil tablets used for the treatment of erectile dysfunction in the US market.
The company has launched Sildenafil tablets USP in the strengths of 25 mg, 50 mg and 100 mg after receiving approval from the United States Food and Drug Administration (USFDA) earlier, Lupin said in a filing to the BSE.
The company's product is the generic version of Pfizer Inc's Viagra tablets in the same strengths, it added.
As per IQVIA MAT July 2019 data, Sildenafil tablets USP, 25 mg, 50 mg, and 100 mg had total annual sales of around USD 216 million in the US, Lupin said. Sildenafil tablets are indicated for the treatment of erectile dysfunction, it added.
Shares of Lupin Ltd on Monday closed at Rs 715.85 per scrip on the BSE, down 0.09 per cent from its previous close.
Get the best of News18 delivered to your inbox - subscribe to News18 Daybreak. Follow News18.com on Twitter, Instagram, Facebook, Telegram, TikTok and on YouTube, and stay in the know with what's happening in the world around you – in real time.
|Dr Reddys Labs||2,810.75||3.15|
Recommended For You
- Nach Baliye 9: Shraddha Arya Says Judge Raveena Tandon wasn't Concentrating on Her Performance
- This 91-Year-Old Couple's 72nd Wedding Anniversary Photoshoot is Melting Hearts Online
- BCCI President Has Not Spoken to Me on MS Dhoni: Virat Kohli
- Disha Patani Shares Insta Story Featuring Tiger Shroff, Captions it 'Bhai Bhai'
- NBA 2K20 Gameplay Will Unlock Limited Edition Nike Sneakers That You Can Buy